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Spontaneous rupture ofthe spleen is a rare complication ofinfectious mononu-
cleosis (IM) occurring in 0.1-0.5 percent of patients with proven IM [1].
Although splenectomy has been advocated as the definitive therapy in the past,
numerous recent reports have documented favorable outcomes with non-opera-
tive management. A review of the literature suggests that non-operative man-
agement can be successful if appropriate criteria, such as hemodynamic stabil-
ity and transfusion requirements are applied in patient selection. We report the
case ofa 36 yearold man with infectious mononucleosis who had a spontaneous
splenic rupture and who was successfully managed by splenectomy. Based on
review of the literature, an approach to management of a spontaneously rup-
tured spleen secondary to IM is suggested.
INTRODUCTION
Infectious mononucleosis (IM)b is a common disease of young adults. The etiologic
agent, the ubiquitous Epstein-Barr virus (EBV), is transmitted primarily through exchange
ofsaliva but can also be transmitted with transfusion ofblood and blood products. Primary
infections with the virus tend to occur at an early age and are usually subclinical.
Approximately 50 percent of pre-adolescent children seroconvert, that number climbing
to 90-95 percent by adulthood [2]. Ofthe people that become primarily infected with EBV
during the latter part ofadolescence and young adulthood, 25-70 percent develop the clin-
ical syndrome ofinfectious mononucleosis.
IM is defined by a clinical triad offever, pharyngitis and lymphadenopathy as well as
the presence ofheterophil antibodies and atypical lymphocytes. It is a self-limited disease,
with pharyngitis resolving in 7-10 days, fever in 7-14 days and lymphadenopathy by about
3 weeks. Splenomegaly is noted clinically in approximately 50 percent of patients,
although by ultrasound, splenic enlargement has been shown to occur in as many as 100
percent ofpatients [3]. Approximately 90 percent ofpatients have hepatitis with mild ele-
vations in serum transaminases [4].
Although the disease usually runs a benign course, approximately 0.1-0.5 percent of
patients with IM suffer spontaneous splenic rupture [5]. Splenic rupture is typically her-
alded by abdominal pain. Signs ofhypovolemia, such as tachycardia, orthostasis and syn-
cope, may also be present. The presence of Kehr's sign (left shoulder pain), occurs in
about 50 percent of splenic ruptures and is another clinical clue to alert the physician to
the possibility ofsplenic rupture. Diagnosis can be made by abdominal ultrasound or CT
scan.
In the face of hemodynamic instability, splenectomy is the treatment of choice.
However, when the patient is hemodynamically stable, management becomes a source
of debate. Though most authors still favor splenectomy, recently, several authors have
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advocated non-operative management as a viable alternative [4, 6]. We report the case
of a 36 year old previously healthy male with spontaneous splenic rupture and infectious
mononucleosis. The patient presented with hemodynamic instability and was success-
fully managed surgically.
CASE REPORT
M.P., a 36 year old male with a history significant for peptic ulcer disease, presented
to the Emergency Department with a four-day history offever, chills, nausea, diarrhea and
anorexia. On the day of admission, he noted the onset of acute abdominal pain localized
to the epigastric area without any radiation. The pain was described as constant and
severe. The patient experienced a syncopal episode thatmorning while attempting to raise
himselffrom his bed, which led him to seek medical attention. The patient denied any his-
tory of recent trauma.
Upon his arrival at the Emergency Department, the patient complained of moderate
abdominal pain. He had a temperature of99.8°F, pulse of 101 and supine blood pressure
of 80/38. He was noted not to have any evidence ofpharyngitis or lymphadenopathy. His
abdominal exam revealed tenderness to percussion and palpation with involuntary guard-
ing in the upper abdomen and rebound tenderness localized to the epigastic region. His
extremities were cool with faint distal pulses.
Laboratory data revealed a white blood cell count of 26,500 cells/ml with 30 percent
atypical lymphocytes and a hematocrit of 32.7. Serum transaminases were slightly elevat-
ed with an alanine aminotransferase value of 294 ufl and an aspartate aminotransferase
value of 172 u/I. Serum alkaline phosphatase was also elevated at 326 ull.
The patient's atypical lymphocytosis, consistent withIM, combined with his clinical
presentation ofperitonitis and hypotension in the absense of a history of trauma, suggest-
ed the tentative diagnosis of a spontaneous splenic rupture. He was started on crystalloids
for fluid replacement but was not given any blood transfusions. While awaiting a CT scan
to confirm his diagnosis, the patient had several episodes of marked hypotension despite
aggressive fluid replacement. Because of his hemodynamic instability, the decision was
made to treat the patient surgically. At laparotomy, there was a large amount of fresh and
clotted blood in the abdomen, and the spleen was large and congested. It had a 6 cm lin-
ear laceration involving the hilum, as well as a subcapsular hematoma on the lateral sur-
face. The spleen was removed without incident and no other intra-abdominal pathology
was noted.
Pathologic examination revealed an enlarged spleen, weighing 310 g. The splenic
parenchyma showed marked infiltration with a heterogeneous population of small lym-
phocytes, activated lymphoid cells, immunoblasts, plasma cells and histiocytes. Marker
studies demonstrated the majority of lymphoid cells to be of T-immunophenotype com-
patible with the clinical diagnosis of an active EBV infection. In situ hybridization for
EBV with EBER oligonucleoprobes was positive for the presence of the virus.c A
Monospot test obtained at the time of admission was later confirmed as positive for infec-
tious mononucleosis.
c EBERs are nonpolyadenylated RNA polymerase III transcripts that are abundant in EBV-infected
cells. The EBER oligonucleoprobes are antisense probes that hybridize to EBER viral RNAs in clin-
ical specimens. In situ hybridization with these probes is considered to be a very sensitive technique
for detecting EBV immortalized cell lines due to the high copy number of the target within infect-
ed cells [7, 8].
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DISCUSSION
Splenic involvement in IM is common: being clinically evident in 25-50 percent and
detectable on ultrasound examination in as many as 100 percent ofpatients [3]. Grossly,
the spleen appears boggy and edematous, often with lifting ofthe splenic capsule forming
a subcapsular hematoma. Histologically, the red pulp appears congested with lymphocyt-
ic and atypical lymphoid cell infiltration. This infiltration extends to include the capsule,
supporting trabeculae, and blood vessel walls of the spleen. As a result, the splenic cap-
sule and fibrous support network may become fragmented and dissoluted, compromising
the spleen's architecture and facilitating rupture.
Etiologic factors that may induce spontaneous splenic rupture include an acute
increase in portal venous pressure such as that accompanying aValsalva maneuver or any
sudden compression of the enlarged spleen secondary to contraction of the diaphragm or
abdominal wall [9]. The spleen is most vulnerable to rupture approximately 10-21 days
after onset of clinical symptoms of IM when capsular and trabecular changes are most
pronounced. In our case, the spleen spontaneously ruptured 4 days after the onset ofclin-
ical symptoms ofIM. Early rupture, though unusual, has been reported as early as 3 days
following the onset of symptoms [10].
Spontaneous splenic rupture secondary to IM was first reported in the literature by
King in 1941 [11]. Five years later, Smith and Custer [12] demonstrated a mortality rate
ofapproximately 30 percent. Although this mortality rate was based on only seven cases,
it was so alarmingly high that it led physicians to view splenectomy as the treatment of
choice for the disease. Other forms of treatment were mostly overlooked until more
recently, when close examination of the cases revealed that the survival rate for "true"
spontaneous splenic rupture (SSR) was higher than previously estimated [9]. Rutkow
reviewed 107 cases of SSR reported in the world literature up to 1976 and suggested that
only 18 ofthose cases were "true" spontaneous ruptures, occurring in patients with a well-
established histologic and serologic diagnosis of IM. The other 89 cases, when examined
with scrutiny, failed to fulfill criteria for true SSR in that 1) a history of traumatic injury
could not be definitively ruled out; 2) the diagnosis of IM was not serologically con-
firmed; and 3) multi-system disease was present, suggesting the possibility of pathologi-
cal as opposed to spontaneous rupture. Ofthe 18 true SSR cases, the survival rate was 100
percent. Though this estimated survival rate is more likely to be a closer approximation to
the actual survival rate, it is, however, slightly elevated as compared with recent reports
that have documented cases of sudden death due to true SSR fulfilling the above criteria
[2, 13, 14]. Nevertheless, the higher estimated survival rate prompted interest in investi-
gating spleen-sparing methods for treating SSR.
Most authors continue to advocate splenectomy as the treatment ofchoice in SSR [1,
10, 15-19]. They argue that there is no strong evidence that non-operative management is
safe in the short-term or beneficial in the long-run. The sudden death of patients prior to
any medical assistance illustrates the potential morbidity associated with non-surgical
management [1]. They maintain that splenectomy is a safe procedure with low morbidity
and mortality and that, most importantly, it is definitive. They cite the fact that, unlike the
normal spleen which can readily repair itself after trauma, the diseased spleen does not
possess the same reparative capabilities due to the changes in the basic framework of the
organ. The capacity ofthe spleen to regain its immunologic function in patients managed
nonoperatively after a spontaneous splenic rupture has yet to be determined.
In previous decades, splenectomy was unarguably the treatment ofchoice for splenic
rupture because the spleen's immunologic function was obscure. It wasn't until 1952
when a landmark article by King and Schumaker [20] suggested that children who under-
went splenectomies were at greater risk for developing sepsis, thus elucidating the entity
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of post-splenectomy sepsis. Post-splenectomy sepsis is a potentially lethal complication
ofsplenectomy with amortality rate of50 percent to 80 percent [21]. While the incidence
of post-splenectomy sepsis is well-documented in the pediatric population [22], its inci-
dence in teenagers and young adults, who are at greatest risk for IM, is less clear. O'Neal
and McDonald [23] attempted to ascertain the risk of post-splenectomy sepsis in the
asplenic young adult population by following a group of 256 asplenic adults aged 16-91
for a mean observation period of 45 months. The incidence of mortality from fulminant
sepsis was 2.7 percent, a prevalence 540 times that of the normal adult population. This
study was performed prior to the availability ofthe pneumococcal vaccine, which has con-
siderably reduced the risk ofsepsis secondary to pneumococcus. Since the vaccine is only
between 60 percent to 100 percent effective, it has not eliminated the risk ofpneumococ-
cal sepsis [21]. More recent reports have estimated the risk ofpost-splenectomy sepsis to
be less than 1 percent in patients who have undergone splenectomy for trauma [16, 24].
The importance of the spleen in immunologic function was further elucidated with
studies showing that patients with splenectomies had reduced serum IgM levels, an inabil-
ity to switch from IgM to IgG synthesis following secondary immunization [25] as well
as a decreased response to various antigens [26]. The discovery of the spleen's role in
immunologic function fostered changing attitudes favoring splenic conservation. Splenic
conservation involves either splenorrhaphy or non-operative management. Successful
splenorrhaphy has not been reported in IM-induced SSR rupture. There is one report of a
successful splenorrhaphy after a traumatic splenic rupture in a patient with IM [27] in
which a 3 cm laceration was repaired with an omental flap. More recently, an attempt at
splenorrhaphy was made in a patient with SSR due to IM but was abandoned secondary
to splenic disintegration during repair [28]. Many surgeons are unwilling to perform
splenorrhaphy in IM due to the inherent fragility of the diseased spleen, which may ren-
der it more vulnerable to further hemorrhage following repair.
The advantages of non-operative management are that it eliminates the risk of post-
splenectomy sepsis and saves the patient from potential perioperative complications.
However, nonoperative management is not without risk. The patient may be prone to
delayed splenic rupture and as a result, may require a longer period of follow-up with
slower return to normal activities. The spleen can remain susceptible to rupture after all
clinical, hematologic and serologic criteria document resolution of IM [9]. Johnson et al.
[29] reported two patients with SSR occurring 4 and 7 weeks after the initial onset of IM.
MacLean [30] reported a patient with recurrent spontaneous splenic rupture 69 days after
hospitalization for splenic rupture secondary to IM. Since the length oftime during which
a patient with IM is at risk for splenic rupture remains uncertain, nonoperative manage-
ment requires months of follow-up as well as restriction of activity for a 2-3 month peri-
od [9, 29]. This is often poorly tolerated in the young adult population.
Additionally, conservatively managed patients may require multiple blood transfu-
sions with the attendant risk ofviral transmissions. Forviruses that can cause chronic, life-
threatening infections, such as the hepatitis viruses and HIV, the results could be fatal.
Fortunately, with the current screening of blood and blood products, that risk is mini-
mized. For example, the risk of post-transfusion transmission of hepatitis C, which prior
to anti-HCV screening in 1990 was estimated to be as high as 13 percent, is now as low
as 0.1 percent [31]. Although the current estimation of the post-transfusion risk for trans-
mission of viruses is markedly reduced, the inherent risk, albeit small, continues to per-
sist.
There have been a total of 19 reported cases of successful non-operative management
ofpatients with SSR and IM (Table 1), suggesting that non-operative management isjusti-
fied in select patients. What criteria can be used to select the appropriate patients? In cases
of adult blunt splenic trauma, Longo et al. [38] proposed parameters predicting successful
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outcome as follows: (1) hemodynamic stability; (2) normal level of consciousness (3);
under 50 years old; (4) transfusion requirements ofless than 4 units ofblood; (5) early res-
olution of splenic defects on imaging studies; and (6) rapid resolution of post-traumatic
ileus. Some ofthe same parameters are useful in predicting a successful outcome in SSR.
Few surgeons would advocate non-operative management in the face of hemodynamic
instability or loss of consciousness. Since IM affects mostly the young adult population,
age limitations are not useful. In comparing the 19 cases of successful outcomes of non-
operative management to those that have failed, the most predictive variable appears to be
the number oftransfusions required to achieve hemodynamic stability.
Table 1. Successful non-operative therapy
Reference Blood Units Age Sex Days of Remarks
Transfused (years) Hospitalization
Ali, 1993 [13]
Evard, et al., 1993 [21]
Farley et al., [1]
0 29 M 7 F/u* at 8 mo. revealed
normal sized spleen with
healed laceration
0 18 F 13
2 17 M NA**
0 19 M 7
0 17 M 7 Elective splenectomy after
18 mo. for hypersplenism
Fleming, 1991 [32] 2
Gauderer et al., 1989 [33] 2
0
Gordon et al., 1995 [19] 0
Howman-Giles et al., 1978 [34] NA
Johnson et al., 1981 [29] Transfusion
performed,
No. units NA
0
Peters & Gordon, 1986 [35]
Ruiz et al, 1990 [36]
Schuler & Filtzer, 1995 [37]
23 M 13
17 M 14
16 F 14 Blunt abdominal trauma
without sequelae 3 mo.
after discharge
22 M 10 Normal splenic architec-
ture at 3 mo. f/u
NA NA NA
14 M NA
14 F NA
0 23 M NA
8 28 M NA
0 17 F NA
2 19 M 12
1 22 F 6
1 21 M 6
Stable amount ofintra-
splenic fluid collection at
4 mo. f/u
Hospital course compli-
cated by SOBt and laryn-
gospasm and intubation
All patients symptom free
at 1 year f/u
* F/u: follow-up;
** NA: not available, t SOB: shortness ofbreath.
In the cases reviewed, 16 of 19 patients who were successfully managed non-opera-
tively required up to 2 units ofblood to maintain hemodynamic stability. Ten required no
transfusions [1, 13, 21, 19, 29, 33, 36], 2 required 1 unit [37] and four required 2 units [1,
32, 33, 37]. One patient required 8 units and subsequently developed shortness of breath
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and laryngospasm requiring intubation [35], suggesting that non-operative management
requiring numerous transfusions may lead to further complications.
In contrast, the available data show that most patients who failed non-operative ther-
apy did so because of persistent hemodynamic instability requiring 5 or more units of
blood (Table 2). The one exception is the patient reported by MacLean [30] who was ini-
tially successfully managed with nonoperative treatment. Upon admission, she stabilized
hemodynamically with administration of 2 units of packed red blood cells and was dis-
charged after 17 days with no complications. However, nine days later, she suffered blunt
trauma to her abdomen at which point she developed recurrent left shoulder pain. This
pain did not resolve and ultimately led to a laparotomy, which indicated delayed splenic
rupture. This case suggests that the spleen may remain susceptible to delayed rupture for
several months, though the exact length oftime has yet to be determined. Thus, non-oper-
ational management should be reserved for patients who can tolerate strict restrictions on
activity.
Table 2. Unsuccessful non-operative therapy
Reference Blood Units Age Sex Days Remarks
Transfused Hospitalized
Farley et al., 1992 [1] NA* 17 F NA Splenectomy forhemodynamic insta-
bility 24 hrs after admission
NA 28 M NA Splenectomy forhemodynamic insta-
bility 7 d. after admission
Gordon et al., 1995 [19] 7 20 M NA Splenectomy forhemodynamic insta-
bility 5 d. after admission
5 20 M NA Splenectomy for hemodynamic insta-
bility 4 hrs after admission
18 57 M NA Splenectomy forhemodynamic insta-
bility 36 hrs after admission
McLean et al., 1987 [30] 2 14 F 7 Initially managed with 2 units
pRBCs.** Readmitted twice for
RUQt pain. Splenectomy 69 d. after
presentation
Vezina et al., 1984 [39] NA 20 M NA Splenectomy 1 week after admission
Vitello, 1986 [17] 6 16 M NA Splenectomy forhemodynamicinsta-
bility
* NA: not available;
** pRBCs: packed red blood cells; tRUQ: Right upper quadrant
SUMMARY
Spontaneous splenic rupture is the most common fatal complication of IM. A high
index of suspicion is necessary on the part of the physician to diagnose the disease and
initiate appropriate management. Although splenectomy is still the treatment ofchoice for
the majority ofpatients with spontaneous splenic rupture, carefully selected patients may
benefit from non-operative management. Previous reports have failed to state how patients
were selected for non-operative management. We propose selecting those patients with
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SSR who require no more than 2 units of blood to maintain hemodynamic stability. Any
such guidelines, however, would need to be investigated with a retrospective study to fur-
ther analyze patients treated both surgically and non-operatively. Establishment of such
guidelines for decision making could facilitate recognition ofthe point at which non-oper-
ative therapy fails and surgical intervention is indicated.
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